Literature DB >> 16225766

Direct and indirect role of Toll-like receptors in T cell mediated immunity.

Damo Xu1, Haiying Liu, Mousa Komai-Koma.   

Abstract

Toll-like receptors (TLRs) are pathogen-associated molecular patterns (PAMPs) recognition receptors that play an important role in protective immunity against infection and inflammation. They act as central integrators of a wide variety of signals, responding to diverse agonists of microbial products. Stimulation of Toll-like receptors by microbial products leads to signaling pathways that activate not only innate, but also adaptive immunity by APC dependent or independent mechanisms. Recent evidence revealed that TLR signals played a determining role in the skewing of naive T cells towards either Th1 or Th2 responses. Activation of Toll-like receptors also directly or indirectly influences regulatory T cell functions. Therefore, TLRs are required in both immune activation and immune regulation. Study of TLRs has significantly enhanced our understanding of innate and adaptive immune responses and provides novel therapeutic approaches against infectious and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16225766

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  18 in total

1.  A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.

Authors:  Chunmei Cheng; Pooja Jain; Ilham Bettahi; Sukumar Pal; Delia Tifrea; Luis M de la Maza
Journal:  Vaccine       Date:  2011-07-08       Impact factor: 3.641

Review 2.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

3.  Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 4.  Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation.

Authors:  Tracy Raymond; Matthew Schaller; Cory M Hogaboam; Nicholas W Lukacs; Rosemary Rochford; Steven L Kunkel
Journal:  Proc Am Thorac Soc       Date:  2007-12

5.  Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.

Authors:  Chunmei Cheng; Ilham Bettahi; Maria I Cruz-Fisher; Sukumar Pal; Pooja Jain; Zhenyu Jia; Jan Holmgren; Ali M Harandi; Luis M de la Maza
Journal:  Vaccine       Date:  2009-08-15       Impact factor: 3.641

6.  Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation.

Authors:  Toshihiro Ito; Matthew Schaller; Tracy Raymond; Amrita D Joshi; Ana L Coelho; Fabiani G Frantz; William F Carson; Cory M Hogaboam; Nicholas W Lukacs; Theodore J Standiford; Sem H Phan; Stephen W Chensue; Steven L Kunkel
Journal:  Am J Respir Crit Care Med       Date:  2009-09-24       Impact factor: 21.405

7.  Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Authors:  Jianwu Pei; Xicheng Ding; Yaping Fan; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

8.  Toll-like receptors in secondary obstructive cholangiopathy.

Authors:  A G Miranda-Díaz; H Alonso-Martínez; J Hernández-Ojeda; O Arias-Carvajal; A D Rodríguez-Carrizalez; L M Román-Pintos
Journal:  Gastroenterol Res Pract       Date:  2011-10-27       Impact factor: 2.260

9.  Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin.

Authors:  C Maletzki; U Klier; W Obst; B Kreikemeyer; M Linnebacher
Journal:  Clin Dev Immunol       Date:  2012-11-11

10.  Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines.

Authors:  Matthew A Schaller; Rupak Neupane; Brian D Rudd; Steven L Kunkel; Lara E Kallal; Pamela Lincoln; John B Lowe; Yunfang Man; Nicholas W Lukacs
Journal:  J Exp Med       Date:  2007-11-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.